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Brain stem tumors in children – therapeutic results in patients
of the University Children’s Hospital of Cracow in Poland
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Joanna Bartoszewska1
A i m.  To analyse the treatment results achieved in children treated for brain stem tumours at one institution between the years
1990 and 2004.
M a t e r i a l.  20 patients (10 girls, 10 boys) aged 2.8-15.6 years were treated for brain stem tumors at the University Children’s
Hospital of Cracow (UCHC) in the years 1990-2004.
The tumour type was defined basing on imaging studies (CT, MRI), and, in the case of 7 patients, additionally basing on
histopathological results. In the collected material the predominant tumor type was benign glioma, detected in 17 patients.
Malignant gliomas were diagnosed in 3 children.
M e t h o d.  7 children were treated by radiotherapy only. Surgical procedures and adjuvant radiotherapy were employed in 3
patients. 6 children underwent radiotherapy and chemotherapy. Combined surgical treatment followed by radiotherapy and
chemotherapy was employed in 4 patients.
Re s u l t s.  Of the 20 patients 6 have died (30%). The surviving group (70%) includes 1 patient with tumor progression (5%),
5 – with stable tumors (25%), and 8 (40%) – with tumor regression. The probability of three-year overall survival for the
entire group as calculated by the Kaplan-Meier method was 70% while the probability of three-year progression-free survival
was 65%.
C o n c l u s i o n s.  Diffuse brain stem tumors, mostly those involving the pons, and malignant gliomas have poor prognosis. In
the presented material we achieved the best treatment results in patients with exophytic or focal tumors, treated surgically with
adjuvant therapy.
Guzy pnia mózgu u dzieci – wyniki leczenia w materiale 
Uniwersyteckiego Szpitala Dzieci´cego w Krakowie
Wprowadzenie.  20 pacjentów (10 dziewczynek i 10 ch∏opców) w wieku 2,8-15,6 lat z nowotworami pnia mózgu by∏o
leczonych w Uniwersyteckim Szpitalu Dzieci´cym (USD) w Krakowie w latach 1990-2004.
C e l  p r a c y.  Ocena wyników leczenia dzieci z nowotworami pnia mózgu w materiale USD.
M a t e r i a ∏.  Na podstawie badaƒ obrazowych (KT, NMR), a u 7 pacjentów dodatkowo w oparciu o badanie histopatologiczne,
okreÊlono typ nowotworu. W materiale w∏asnym przewa˝a∏y guzy o charakterze glejaka ∏agodnego: u 17 pacjentów. Glejaki
z∏oÊliwe zdiagnozowano u 3 dzieci.
M e t o d a.  Samà radioterapià leczono 7 dzieci. Chirurgi´ z nast´powà radioterapià zastosowano u 3 pacjentów. Radioterapi´
z chemioterapià stosowano u 6 dzieci. Skojarzonemu leczeniu operacyjnemu z nast´powà radio- i chemioterapià poddano
4 pacjentów.
W y n i k i.  Z 20 pacjentów leczonych w Uniwersyteckim Szpitalu Dzieci´cym w Krakowie w latach 1990-2004 z powodu guzów
pnia mózgu, 6 zmar∏o (30%), a 14 pacjentów ˝yje (70%), w tym 1 z progresjà choroby (5%), 5 ze stabilizacjà (25%) oraz
8 z regresjà guza (40%). Prawdopodobieƒstwo prze˝ycia 3 letniego ca∏kowitego oraz 3 letniego bez progresji choroby oceniono
na podstawie krzywych prze˝yç Kaplana-Meiera; wynios∏o ono dla prze˝yç ca∏kowitych 70%, a dla prze˝yç bez progresji
choroby 65%.
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Introduction
More than 70% of tumors situated in the brain stem – in
the mesencephalon, the pons and the medulla oblongata
– are encountered in patients below 20 years of age [1].
They account for 10 to 20% of brain tumors in children;
in the present material this ratio reached 14% (20 patients
treated in the years 1990-2004). In the United States
some 150-300 cases are detected annually [1, 2]. These
tumors are most common in the 7-9 years age group and
show no significant difference in their distribution
between both sexes. Histologically, the predominant type
is glioma with varying degrees of malignancy. Other brain
stem tumors include PNET, lymphomas, cavernomas and
epidermal cysts [1, 3]. In neurological and neurosurgical
practice we use the classification presented by Epstein. It
classifies these tumors as diffuse, focal, cystic, exophytic
and tumors of the craniovertebral region [4].
Clinical symptoms vary according to tumor type,
location and patient age. In exophytic tumors of the
fourth ventricle and the tectal lamina, the predominant
symptoms include intracranial hypertension associated
with hydrocephalus. In diffuse tumors, especially involving
the brain stem, the clinical symptoms develop rapidly and
include balance problems, muscular hypotonia, dysmetria
and cranial nerve damage. In tumors involving the
medulla oblongata and the cervical segment of the
medulla, the frequently encountered symptoms include
persistent hiccups, recurrent infections of the upper
respiratory tract, changed timbre of voice and altered
way of speaking. All groups of brain stem tumors are
characterized by such initial symptoms as eye movement
abnormalities – divergent squint with or without double
vision, abnormal accommodation and Parinaud’s sign.
The management of brain stem tumors includes surgery,
radiotherapy and chemotherapy, or a combination of
these therapeutic modalities.
Objective
To sum up and assess the therapeutic results achieved in
children with brain stem tumors managed at the
University Children’s Hospital of Cracow in the years
1990-2004.
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W n i o s k i.  Rozlane guzy pnia, g∏ównie mostu oraz z∏oÊliwe glejaki charakteryzuje z∏e rokowanie. W materiale w∏asnym
najlepsze wyniki osiàgni´to u pacjentów z guzami o charakterze egzofitycznym lub ogniskowym, leczonych operacyjnie
z nast´powym leczeniem uzupe∏niajàcym.
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Table I. Patient and disease characteristics
Age Gender Histopathology Tumor Therapeutic Assessment 
growth type modalities of response 
to therapy
A.W 6.1 M None diffuse RT P, death
K.S 6.0 M None diffuse RT CR
T.J 12.6 F None exophytic RT CR
C.G 4.7 M None exophytic RT PR
S.P 6.1 F None focal RT P, death
P.P 13.0 F None focal RT P, death
P.M 15.6 F None focal RT PR
R.N 14.1 M a. fibrillare partim bipolare focal OP+RT S
˚.M 14.6 F a. fibrillare partim bipolare focal OP+RT S
Z.D 9.5 M a. pilocyticum exophytic OP+RT S
¸.D 11.1 M None diffuse CHT+RT CR
W.D 13.1 F None exophytic CHT+RT PR
M.E 11.9 F None exophytic CHT+RT P, death
S.E 13.6 F None focal CHT+RT PR
M.S 13.0 M None focal CHT+RT S
F.A 4.3 M None focal CHT+RT P, death
H.T 4.8 M a. pilocyticum exophytic OP+CHT+RT S
S.¸ 13.6 M a. pilocyticum exophytic OP+CHT+RT P, death
B.K 2.8 F a. fibrillare partim bipolare exophytic OP+CHT+RT PR
R.M 8.1 F a. fibrillare partim bipolare exophytic OP+CHT+RT P
Legend: CR – complete regression, PR – partial regresssion, S – stabilization, P – progression
Material
Between 1990 and 2004, 20 children aged from 2.8 to 15.6 years
were treated at the University Children’s Hospital of Cracow; the
group was equally divided into boys and girls. Prior to treatment,
all the children underwent CT scans, and 12 patients were
additionally diagnosed using MRI, thus confirming the presence
of a tumor in the brain stem. The tumour type was pronounced
basing on the imaging studies and, in the case of the 7 surgical
patients, additionally basing on histopathology. Table I presents
the patient characteristics.
Method
7 children underwent surgical treatment followed by adjuvant
therapy – subsequent radiotherapy in 3 cases and radiotherapy
and chemotherapy in 4 cases. Due to inoperable disease, 13
children were treated conservatively – 7 by radiotherapy alone,
and 6 by radiotherapy and chemotherapy.
C o n s e r v a t i v e  t r e a t m e n t
Radiotherapy was employed in 7 children (age at diagnosis: 4.7-
15.6 years) – 3 boys and 4 girls. Surgical intervention consisted of
implanting a ventriculo-peritoneal valve and was performed in 4
children. Due to tumor location the patients did not qualify for
tumor resection. Prior to treatment, all the patients presented
with neurological symptoms, which depended on tumor location.
Pronounced personality changes, manifested as aggression and
anxiety, were observed in one child with a lesion situated in the
pons. Deterioration of the clinical and the neurological status in
the course of therapy was noted in one child; this phenomenon
was associated with massive progression of the disease and the
treatment was discontinued.
In the course of treatment, the remaining patients
manifested considerable clinical and neurological improvement,
including a girl, in whom disease progression occurred 4 months
after the completion of therapy.
R a d i o t h e r a p y  a n d  c h e m o t h e r a p y
The treatment was employed in 6 patients aged between 4.3
and 13.6 years – 3 girls and 3 boys. Surgical procedures
(implantation of a ventriculo-peritoneal valve) were performed
in 3 children. Due to the detection of astrocytoma cells in the
cerebrospinal fluid, one child was subjected to irradiation of
the entire central nervous system, with an increased dose applied
to the tumor site. Following preliminary chemotherapy according
to the protocol established by the Polish Pediatric CNS Tumor
Group, 2 children manifested massive tumor growth. Since
a surgical intervention was impossible, the patients underwent
radiotherapy. During the irradiation therapy, the children had
already considerably improved clinically and neurologically,
while CT scans showed tumor regression.
S u r g e r y  c o m b i n e d  w i t h  s u b s e q u e n t
a d j u v a n t  t h e r a p y
Surgical procedures with subsequent radiotherapy were
employed in 3 children – 2 boys and a girl – aged 9.5-14.6 years.
S u r g e r y  w i t h  r a d i o t h e r a p y  a n d
c h e m o t h e r a p y
The group included 4 children aged 2.8-13.6 years (2 boys and 2
girls). In all these children partial tumor resection procedures
were performed and followed by chemotherapy and radio-
therapy. Two patients managed in the earlier period were treated
according to the VCR+CCNU protocol, one child was on
Temodal, and one was managed according to the protocol
established by the Polish Pediatric CNS Tumor Group.
Results
Of the twenty patients treated at the University Children’s
Hospital of Cracow due to brain stem tumors in the
period 1990-2004, 6 died (30%) and 14 survived (70%) –
1 patient with tumor progression (5%), 5 – with stabilized
tumors (25%) and 8 (40%) – with tumor regression. In
the latter group 5 children demonstrate partial, and 3 –
complete tumor regression. Partial tumor resection
procedures were performed in 7 children. Radiotherapy
was employed in all 20 patients. In addition, chemo-
therapy was employed in 10 children. Long-term survivals
(10 and 14 years) were achieved in 2 patients. These
children had exophytic gliomas involving the pons and
the pons and medulla oblongata, which were treated by
radiotherapy alone, resulting in one total and one partial
regression of the tumor, maintained for 6 years and
8 months, respectively. The latter child was subsequently
operated on due to a recurrent tumor. At present, 14.5
years after treatment completion, the patient is alive and
symptom-free. 3 children achieved total survival ranging
from 5 to 9 years. Two of these patients had partial tumor
resection, followed by adjuvant irradiation therapy. One
patient with a focal glioma of the medulla oblongata is
alive, with stabilized disease maintained for 5 years,
another child with an exophytic glioma involving the
medulla oblongata and pons was operated on after a 5-
year stabilization period due to a recurrent tumor; this
patient is presently (9.2 years after the initial diagnosis)
alive and symptom-free.
Particularly worthy of consideration is a patient with
an exophytic tumor of the mesencephalon and pons, in
whom – following surgical tumor tissue collection (no
neoplastic cells were demonstrated in the material) and
implantation of a ventriculo-peritoneal valve – only one
cycle of CCNU+VCR chemotherapy was administered.
In view of the deteriorating general condition of the child,
adjuvant therapy was discontinued and the patient was
referred for symptomatic treatment. Over a period of
two years, CT demonstrated spontaneous shrinking of the
tumor mass and the child improved clinically and
neurologically. After that, the disease progressed and
irradiation therapy was employed, resulting in a moderate
regression of the tumor as demonstrated by imaging
techniques, and in view of considerable clinical impro-
vement. After another three years, the disease progressed
and the tumor was partially resected (histopathological
diagnosis: astrocytoma pilocyticum). At present, 6.8 years
after the onset of symptoms, the patient is alive and in
a very good general condition, his disease is stabilized,
which has been confirmed by imaging studies.
Survival curves for the entire group were generated
by the Kaplan-Meier method. (Figures 1, 2). The length
of survival was calculated from the data of diagnosis. The
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survival length in particular therapeutic groups is
demonstrated in Table II.
Discussion
Brain stem tumors pose a serious therapeutic problem. In
spite of the development of neurosurgical techniques,
often a radical or even a partial procedure is impossible to
perform in the case of tumors situated in the pons or in
the case of the so-called diffuse brain stem gliomas. Five-
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Figure 1. Kaplan-Meier overall survival analysis
Figures 2. Kaplan-Meier progression – free survival analysis
Table II. Mean total and event-free survivals 
in particular therapeutic groups
Number Therapeutic modalities PFS OS 
of patients (years) (years)
13 Conservative treatment:
RT and RT+CHT 3.8 3.9
7 Surgery with adjuvant treatment:
OP+RT and OP+CHT+RT 4.5 4.7
Legend: PFS – progression free survival, OS – overall survival
year survival rates in this group oscillate between 10 and
30% [1]. In our material there were 4 patients with
tumors located in the pons, 5 with tumors in the
mesencephalon, and 6 – in the medulla oblongata. In
the case of 2 children, the tumor infiltrated the pons
and the medulla oblongata, in 3 – the pons and the
mesencephalon.
In view of the composition of the patient group,
which included children mostly with advantageous
location of the tumor, our results (85% children with
advantageous location) are similar to those presented in
literature. As follows from numerous reports published in
medical periodicals, which of necessity are scarce in view
of the relatively low incidence of the disease, to date, in
randomized multicenter clinical trials based on large
groups of patients no effective therapeutic modality has
been identified which would ensure a high percentage of
event-free survival. Surgical management continues to
play a leading role only in patients with exophytic
tumours. Radiotherapy is also a therapeutic standard,
especially for diffuse tumors. Unfortunately, investigations
on the use of hyperfractionated, accelerated and
hyperfractionated accelerated radiation therapy have not
contributed to an improvement in the outcomes [5, 6].
Therapeutic results have also failed to improve – as may
be seen from the group of 28 children subjected to
brachytherapy with I-125 implants in whom the dose of
82.9 Gy was employed [7]. In adult patients with brain
stem tumors, investigations concentrate on stereotactic
radiotherapy [8].
The use of chemotherapy in managing brain stem
tumors in children is the subject of numerous clinical
trials; unfortunately, at present only phase I or II. Thus,
the Children’s Cancer Group (CCG) has been testing
Toptecan as a radiosensitizer administered in combination
with conventional radiotherapy. In the phase I clinical
trial, the 1-year survival rate in 17 children was 53% [9].
Phase II results of the same study carried out by CCG
were published in 2002; the trial included 63 children
randomized into two groups. Group 1 received three
cycles of chemotherapy (carboplatin, etoposide and
vincristin), while Group 2 was administered three cycles of
cisplatin, etoposide, cyclophosphamide and vincristin. In
both groups, chemotherapy was employed prior to
hyperfractionated radiation therapy. In Group 1, 10±5%
children responded to chemotherapy. After radiotherapy,
the percentage of responders increased to 27%±9%. In
Group 2, a response to chemotherapy was achieved in
19%±8%. After radiotherapy, however, the percentage
increased to 23%±9%. The 1-year event-free survival
rate for all patients equaled 17%±5%, while the 2-year
survival rate was 6%±3% [10]. Also in clinical trials
performed by French investigators on 38 children and
published in 2002, two cycles of carboplatin administered
prior to irradiation and followed by carboplatin employed
simultaneously with conventional radiotherapy failed to
improve survival rates [11].
In our material, the largest group (17 patients)
consisted of children with brain stem tumors with the
type of growth that is associated with a more favorable
prognosis – exophytic or focal. Three children had the
so-called diffuse brain stem glioma. When comparing the
survivals as calculated from the onset of therapy in
particular therapeutic groups, one notes that the longest
survivals were achieved in patients with exophytic or focal
tumors, who were treated surgically and subjected to
adjuvant radio- or chemo- and radiotherapy. However,
the analyzed groups were small and not uniform in
character, and thus did not facilitate an objective
assessment of the material.
What is striking in our 14 survivors is their good
general and neurological state. All the children resumed
schooling. Three patients presently attend primary schools
(two of them are taught individually at home), while five
continue their secondary level education, including two
patients taught in the individual system. Four patients
have completed secondary level education; one boy
is a university student. Due to disease progression, one
patient is unable to continue education. In the group
of patients which we have been following up, three
years after radiotherapy completion, 60% of school-
children have started to experience problems with
memorizing text. However, with an increased effort on the
part of the patients, teachers and parents, their school
performance continues to be good, and allows to
complete secondary school and even commence university
education. Serious complications of the therapy include
endocrine abnormalities. In the majority of cases such
disturbances include deficits of thyroid hormones, sex
hormones and the growth hormone, which require
substitution therapy. In the present material, the authors
have not observed hearing loss, which has been reported
by other investigators [12]. As follows from the publi-
cations on the subject, long-term survival rates are
achieved in children with cystic and exophytic tumors, in
case of which partial or subtotal tumorectomies are
possible and can be followed by adjuvant therapy [2]. In
these cases the long-term survival rates are above 50%.
Our results are comparable with data reported by various
authors, however, our group of patients is small and non-
homogenous.
Conclusions
1. Brain stem tumors constitute a heterogeneous group of
neoplasms characterized by a variable degree of
biological malignancy.
2. Data obtained in MRI studies and from the clinical
presentation have allowed to establish a classification
of these tumors and to develop a management
protocol.
3. In the vast majority of our patients (17), brain stem
tumors are focal and exophytic in character. In such
patients, long-term survivals are achieved.
4. Diffuse brain stem tumors, mostly involving the pons
(80%), as well as malignant gliomas are associated
with poor prognosis (3 patients in our material)
5. In our material, the best results have been achieved in
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patients, in whom tumor resections were possible,
(even if the procedure was partial) and then were
followed by adjuvant therapy.
6. The probability of three-year overall survival for our
patients was 70%, and progression- free-survival was
65%.
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